Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (606145)	8/26/2016 2:27:06 PM
From: DMaA	1 Recommendation Recommended By FJB Read Replies (1) \| Respond to of 793658

You don't need a conspiracy. It's in plain sight. The reason a company with a product so old its patent is expired can maintain monopoly pricing is because of government regulations.

To: DewDiligence_on_SI who wrote (606145)	8/26/2016 2:48:54 PM
From: alanrs	Respond to of 793658

can't read the fuzzy print. don't have a lot of thoughts about it one way or the other. apparently it is a difficult engineering task, funny how the old ones look like a turkey baster with a knitting needle taped to the end. i exaggerate. ARS

To: DewDiligence_on_SI who wrote (606145)	8/26/2016 4:50:49 PM
From: Jack Be Quick	1 Recommendation Recommended By Alan Smithee Read Replies (1) \| Respond to of 793658

Here’s a good read that contains educated speculation on what’s wrong with Teva’s generic-EpiPen application: seekingalpha.com Well, I read it. I'll admit, I read it quickly. I don't see much speculation on what's wrong or right with Teva's generic EpiPen. I do see a lot of speculation about how many hoops and how much folderol the FDA will make the applicants dance through for FDA's own bureaucratic reasons. Just curious, what specifically in this link that you've provided makes you feel all warm and happy about the FDA wrt the generic EpiPen application?

To: DewDiligence_on_SI who wrote (606145)	8/26/2016 9:06:40 PM
From: Copeland	Respond to of 793658

There are other epinephrine autoinjectors out there. For instance, Adrenaclick can be bought for $125-$150 in most markets. Sanofi used to have a really good one until it got recalled. I don't know if there's a mandate for schools to stock the name brand "Epi Pen" versus the generic alternatives (thereby causing Mylan to jack up the price).

To: DewDiligence_on_SI who wrote (606145)	9/2/2016 11:07:12 AM
From: semi_infinite	Read Replies (1) \| Respond to of 793658

As someone who has had to use the device on somebody else going through an anaphylactic shock, that seeking alpha piece makes absolutely no sense. I was untrained with the Epipen and had to read the instructions first which took a couple minutes to read and think through. The person having the allergic reaction was in no condition to act and certainly not in a state of mind to read instructions. So this training and pre-training with regards to any generic that is similar to the Epipen is just a bunch of horse crap. I don't know to what degree Epipen usage is demonstrated when the pharmacists fills the prescriptions.